Dow Jones

40 954,48

1,85%

DAX

Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NYSE
Teva Pharmaceutical Industries Ltd (TEVA)
Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NYSE:TEVA

<< Précédent 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
22/03/2022	12h47	TipRanks	Teva Settles Opioid Case with Rhode Island, Aims National Settlement	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
21/03/2022	20h45	Dow Jones News	Teva Pharmaceuticals Agrees to Pay Rhode Island $21 Million, Provide Opioid Treatment Options	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
21/03/2022	19h55	Business Wire	Teva Reaches Agreement With Rhode Island to Settle Opioid-Related Claims	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
15/03/2022	21h03	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
08/03/2022	22h14	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
07/03/2022	14h00	Business Wire	Teva Announces Launch of a First Generic Version of Revlimid® (lenalidomide capsules), in the U.S.	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
02/03/2022	13h33	PR Newswire (Canada)	Teva Canada Welcomes Public Drug Plan Reimbursement by Alberta, Saskatchewan, Québec, Veteran Affairs Canada and the Non-Insured Health Benefits Program for Patients prescribed AJOVY® (fremanezumab) for the Preventive Treatment of Migraine in Adults	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
02/03/2022	13h33	PR Newswire (Canada)	Teva Canada se réjouit du remboursement d'AJOVY(MD) (frémanezumab)par les régimes publics d'assurance médicaments de l'Alberta, de la Saskatchewan, du Québec ainsi que par le ACC et le Programme SSNA aux patients prescrit AJOVY(MD)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
24/02/2022	22h11	Edgar (US Regulatory)	Current Report Filing (8-k)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
21/02/2022	14h00	PR Newswire (US)	Bleichmar Fonti & Auld LLP Announce a Proposed Class Action Settlement Involving Purchasers of Teva Pharmaceutical Securities	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
14/02/2022	09h00	Business Wire	COPAXONE®-Etikett indiziert nun Einsatz für stillende Mütter mit schubförmig verlaufender Multipler Sklerose	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
14/02/2022	09h00	Business Wire	La notice de COPAXONE® mentionne désormais son utilisation chez les mères allaitantes atteintes de sclérose en plaques rémittente	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
11/02/2022	18h26	Edgar (US Regulatory)	Schedule 13g	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
10/02/2022	22h16	Edgar (US Regulatory)	Annual Statement of Changes in Beneficial Ownership (5)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
10/02/2022	09h00	Business Wire	COPAXONE® Label Now Indicates Its Use in Breastfeeding Mothers with Relapsing Multiple Sclerosis	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
09/02/2022	22h12	Edgar (US Regulatory)	Annual Report (10-k)	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
09/02/2022	13h00	Business Wire	Teva Reports Fourth Quarter and Full Year 2021 Financial Results	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
07/02/2022	17h01	Dow Jones News	Teva Pharmaceuticals in Deal With Texas Settling Opioid-Related Claims	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
07/02/2022	16h12	Business Wire	Teva Reaches Agreement With Texas to Settle the State’s Opioid-Related Claims	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
01/02/2022	14h00	Business Wire	Research Finds COVID Pandemic Worsened Health Equity Gap	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
19/01/2022	13h11	TipRanks	Teva to Pay $420M to Settle Shareholders’ Generic Drug Pricing Lawsuit — Report	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
18/01/2022	14h00	Business Wire	Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2021 Financial Results and 2022 Financial Guidance at 8 a.m. ET on February 9, 2022	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
04/01/2022	19h35	Business Wire	Teva to Present at the 40th Annual J.P. Morgan Healthcare Conference	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
31/12/2021	17h06	TipRanks	Teva Found Guilty of Fueling New York Opioid Crisis	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
30/12/2021	19h29	Business Wire	Teva Statement Following New York Jury Ruling in Opioids Trial	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
30/12/2021	19h05	Dow Jones News	Teva Fueled Opioid Addiction in New York, Jury Finds -- Reuters	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
29/12/2021	09h27	TipRanks	Teva Long-Term Prospects Bright, Despite Headwinds	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
27/12/2021	10h11	TipRanks	Teva Partners with Tikun Olam-Cannbit to Sell Medical Cannabis Products – Report	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
23/12/2021	14h54	TipRanks	Teva Launches First Generic of Naloxone Hydrochloride Nasal Spray in the U.S.	NYSE:TEVA	Teva Pharmaceutical Industries Ltd
22/12/2021	22h30	Business Wire	Teva Announces Launch of First-to-Market Generic Version of Narcan® (Naloxone Hydrochloride Nasal Spray), in the U.S.	NYSE:TEVA	Teva Pharmaceutical Industries Ltd